FOXM1 and neoplasm: CDK4/6 inhibitors function as ATP competitive inhibitors, while they intervene in the phosphorylation and inactivation of retinoblastoma, a key tumor suppressor fundamental in cell cycle and the inactivation of FOXM-1.